Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines Against Symptomatic SARS-CoV-2 Infection and Severe COVID-19 Outcomes in Ontario, Canada
Author(s) -
Hannah Chung,
Siyi He,
Sharifa Nasreen,
Maria E. Sundaram,
Sarah A. Buchan,
Sarah Wilson,
Branson Chen,
Andrew Calzavara,
Deshayne B. Fell,
Peter C. Austin,
Kumanan Wilson,
Kevin L. Schwartz,
Kevin A. Brown,
Jonathan B. Gubbay,
Nicole E. Basta,
Salaheddin M. Mahmud,
Christiaan H. Righolt,
Lawrence W. Svenson,
Shan E. MacDonald,
Naveed Z. Janjua,
Mina Tadrous,
Jeffrey C. Kwong,
Canadian Immunization Research Network Provincial Collaborative Network Investigators Group
Publication year - 2021
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3845993
Subject(s) - covid-19 , medicine , virology , intensive care medicine , outbreak , infectious disease (medical specialty) , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom